 delivery systems has decreased this number signiﬁcantly. An industry-sponsored trial of a TEVAR
device with delivery systems that range from 16F to 20F
required an iliac conduit in only one (0.9%) patient.177
This low number was aided by strict exclusion criteria
that included iliac tortuosity, calciﬁcation, occlusive disease, and an inner wall diameter that was not adequate
for the required sheath diameter